The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 9th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2022) held in virtual format during 3-5 October, 2022. Due to the COVID-19 Corona virus pandemic, the European Society for Translational Medicine (EUSTM) has revised the 2022 congress format to a virtual event. EUSTM took this initiative to ensure the health and safety of our global delegates.
This Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care.
EUSTM-2022 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.
Call for Abstracts
The European Society for Translational Medicine (EUSTM) 2022 cordially invites researchers/investigators & Clinicians from various disciplines & specialties working on any aspects which have direct implications for translating into immunotherapeutics, to submit Abstracts in all areas outlined under conference themes and tracks. The conference will represent a unique multidisciplinary virtual platform to discuss latest findings, advancements and approaches covering from Biology to Patient Care. Abstracts will be selected for Oral/Poster presentations. The abstracts should be submitted via online submission form.
Abstract Submission Deadline: 30 June, 2022.
Abstract Submission General Guidelines
-
The authors for accepted abstracts for oral talks will need to present oral talk (15/20 minutes) at the congress allocated slot time (live or pre-recorded) with the help of congress management team.
-
The authors for accepted abstracts for poster presentations will need to submit their E-Posters (pdf & 8/10 minutes video presentation).
-
All abstracts will be peer reviewed on rolling basis and presenting author will be notified once the committee decision is made.
-
Abstracts must be submitted via online submission system ONLY. Abstracts submitted via email, fax or by post will not be considered.
-
Please specify preferred presentation format.
-
The accepted abstracts authors will need to register for the congress to confirm their oral/poster presentation slots.
-
Multiple abstracts can be submitted for consideration by one person. But, only one talk per person would be allowed at the congress. Additional accepted abstracts for poster presentation, can be presented by another registered co-authors or by presenting author after paying additional administrative fees.
-
Please select congress track and theme that best describes your submission.
-
Abstract text must not exceed 450 words using 12-Regular Times New Roman font. In addition, up-to 3 tables and/or images can be submitted.
-
All presenters and co-authors must disclose any commercial interest/financial relationship.
-
Please proofread your abstract carefully before submission. Congress team will not be responsible for any typographical errors or other mistakes in the abstract.
-
By submitting an abstract, the presenting author confirms on behalf of all co-authors that all necessary ethical approvals and copyright permissions are obtained and confirms the originality of the work.
-
No further changes in the abstract will be permitted upon acceptance.
-
For technical help regarding abstract submission, please contact conference secretariat via email: [email protected].
Important Links
Click here to submit the abstract online.
Click here to register for the EUSTM Congress on Immunotherapeutics - from Biology to Patient Care.
Contact Information
For any queries, click here.
For more information, click here.